Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ANIX

Anixa Biosciences Inc

Jun 10 • 04:00PM ET

2.35

-0.05 -2.08 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ATYR COYA CYPH INO LONA NRXS CGTX KLRS NRXP KALA

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.30	Insider Own	5.38%	Shs Outstand	33.46M	Perf Week	-6.75%
Market Cap	78.79M	Forward P/E	-	EPS next Y	-0.35	Insider Trans	0.56%	Shs Float	31.72M	Perf Month	-22.44%
Enterprise Value	63.55M	PEG	-	EPS next Q	-0.09	Inst Own	15.20%	Short Float	3.20%	Perf Quarter	-20.07%
Income	-10.03M	P/S	-	EPS this Y	1.47%	Inst Trans	-2.99%	Short Ratio	9.23	Perf Half Y	-54.98%
Sales	0.00M	P/B	5.22	EPS next Y	-4.48%	ROA	-63.02%	Short Interest	1.01M	Perf YTD	-24.68%
Book/sh	0.45	P/C	5.55	EPS next 5Y	-3.32%	ROE	-65.70%	52W High	5.46 -56.93%	Perf Year	-32.66%
Cash/sh	0.42	P/FCF	-	EPS past 3/5Y	9.05% 5.67%	ROIC	-70.53%	52W Low	2.40 -2.08%	Perf 3Y	-31.29%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.00% 5.09%	Perf 5Y	-45.73%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	19.02%	Oper. Margin	-	ATR (14)	0.15	Perf 10Y	-29.22%
Dividend Ex-Date	-	Quick Ratio	9.79	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	30.38	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	9.79	EPS Q/Q	21.94%	SMA20	-11.60%	Beta	0.65	Target Price	11.50
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-16.09%	Rel Volume	1.02	Prev Close	2.40
Employees	4	LT Debt/Eq	0.01	Earnings	Mar 13	SMA200	-29.11%	Avg Volume	109.86K	Price	2.35
IPO	Oct 07, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.21% -	Trades		Volume	113,074	Change	-2.08%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)